Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

41. Appendix B: Risk Assessment Models, Protocols, and Order Sets (continued) | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/resources/vtguide/appb2.html
    January 01, 2020 - spinal lesion at high risk of bleeding, recent major operation at high risk for bleeding, systemic anticoagulant … prophylaxis. … Variation: For scores of 3–4, offer only anticoagulant, or only IPC, depending on the population the … prophylaxis. … prophylaxis.

42. Appendix B: Risk Assessment Models, Protocols, and Order Sets (continued) | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/hospital/vtguide/appb2.html
    January 01, 2020 - spinal lesion at high risk of bleeding, recent major operation at high risk for bleeding, systemic anticoagulant … prophylaxis. … Variation: For scores of 3–4, offer only anticoagulant, or only IPC, depending on the population the … prophylaxis. … prophylaxis.

43. Appendix B: Risk Assessment Models, Protocols, and Order Sets (continued) | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/appb2.html
    January 01, 2020 - spinal lesion at high risk of bleeding, recent major operation at high risk for bleeding, systemic anticoagulant … prophylaxis. … Variation: For scores of 3–4, offer only anticoagulant, or only IPC, depending on the population the … prophylaxis. … prophylaxis.

44. Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research-protocol
    January 12, 2012 - will also evaluate the use of antiplatelet agents, such as aspirin and clopidogrel, as well as the anticoagulant … Dabigatran is a newly developed oral anticoagulant that directly inhibits thrombin; it has been approved … The concern about anticoagulant thromboprophylaxis in this population is progression of intracranial … optimal threshold of thrombocytopenia and the prolonged INR value at which bleeding increases with anticoagulant … Current ACCP guidelines recommend that anticoagulant medications that bioaccumulate should be avoided

45. Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/vte-prophyalaxis/research-protocol
    December 01, 2019 - will also evaluate the use of antiplatelet agents, such as aspirin and clopidogrel, as well as the anticoagulant … Dabigatran is a newly developed oral anticoagulant that directly inhibits thrombin; it has been approved … The concern about anticoagulant thromboprophylaxis in this population is progression of intracranial … Current ACCP guidelines recommend that anticoagulant medications that bioaccumulate should be avoided … [tiab] Anticoagulant[tiab] prevention and control[subheading] thromboembolism[mh] Aspirin

46. Appendix A: Tools and Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/resources/vtguide/appa.html
    July 01, 2018 - Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized … Convincing trials of anticoagulant prophylaxis against symptomatic UE DVT are currently lacking, but … a recent meta-analysis found that anticoagulant prophylaxis is effective for preventing all CVC-related … DVT, and it seems likely that anticoagulant prophylaxis reduces symptomatic UE DVT to some extent. … In any case, most inpatients with a CVC warrant anticoagulant prophylaxis based on cumulative risk factors

47. Appendix A: Tools and Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/hospital/vtguide/appa.html
    July 01, 2018 - Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized … Convincing trials of anticoagulant prophylaxis against symptomatic UE DVT are currently lacking, but … a recent meta-analysis found that anticoagulant prophylaxis is effective for preventing all CVC-related … DVT, and it seems likely that anticoagulant prophylaxis reduces symptomatic UE DVT to some extent. … In any case, most inpatients with a CVC warrant anticoagulant prophylaxis based on cumulative risk factors

48. Appendix A: Tools and Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/appa.html
    July 01, 2018 - Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized … Convincing trials of anticoagulant prophylaxis against symptomatic UE DVT are currently lacking, but … a recent meta-analysis found that anticoagulant prophylaxis is effective for preventing all CVC-related … DVT, and it seems likely that anticoagulant prophylaxis reduces symptomatic UE DVT to some extent. … In any case, most inpatients with a CVC warrant anticoagulant prophylaxis based on cumulative risk factors

49. Reducing anticoagulant medication adverse events and avoidable patient harm. | PSNet
    psnet.ahrq.gov/issue/reducing-anticoagulant-medication-adverse-events-and-avoidable-patient-harm
    May 19, 2021 - Study Reducing anticoagulant medication adverse events and avoidable patient harm … Reducing anticoagulant medication adverse vents and avoidable patient harm. … Hospitalized patients receiving anticoagulants such as warfarin are at high risk for adverse drug events … Reducing anticoagulant medication adverse vents and avoidable patient harm. … View More Related Resources Modes of failure in venous thromboembolism prophylaxis

50. Chapter 3. Outline the Evidence and Identify Best Practices | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/vtguide/guide3.html
    February 01, 2016 - (Nonsurgical) Acutely ill hospitalized patients at risk for thrombosis are likely candidates for anticoagulant … (preferably with IPCD) and anticoagulant prophylaxis is suggested for these high-risk patients. … In AT8 and other guidelines, anticoagulant prophylaxis is preferred over mechanical prophylaxis. 6,13 … arthroplasty and total knee arthroplasty, LMWH is favored by AT9. 4 For hip fracture surgery, the anticoagulant … of anticoagulants in different situations, further complicate the issues.

51. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49476/psn-pdf
    March 02, 2005 - factors include traumatic needle placement, repeated insertion attempts, and concomitant use with anticoagulants … needle or catheter placement during normal hemostasis, administration of the lowest efficacious dose of anticoagulant … For instance, if an anticoagulant was requested on a patient already receiving a typical neuraxial anesthetic … Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994;79:1165-77.[ go to PubMed ] 9.  … administered a dose of LMWH 2 hours preoperatively, because needle placement would occur during peak anticoagulant

52. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - will also evaluate the use of antiplatelet agents, such as aspirin and clopidogrel, as well as the anticoagulant … Dabigatran is a newly developed oral anticoagulant that directly inhibits thrombin; it has been approved … The concern about anticoagulant thromboprophylaxis in this population is progression of intracranial … Current ACCP guidelines recommend that anticoagulant medications that bioaccumulate should be avoided … [tiab] prophyla*[tiab] Pulmonary embolism[tiab] Anticoagulant[tiab] prevention and control[subheading

53. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - will also evaluate the use of antiplatelet agents, such as aspirin and clopidogrel, as well as the anticoagulant … Dabigatran is a newly developed oral anticoagulant that directly inhibits thrombin; it has been approved … The concern about anticoagulant thromboprophylaxis in this population is progression of intracranial … Current ACCP guidelines recommend that anticoagulant medications that bioaccumulate should be avoided … [tiab] prophyla*[tiab] Pulmonary embolism[tiab] Anticoagulant[tiab] prevention and control[subheading

54. Making Healthcare Safer Practices: 16. Venous Thromboembolism (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
    March 01, 2020 - Pharmacologic prophylaxis is available via a number of different anticoagulant and antiplatelet drugs … There are two different types of pharmacologic agents available for VTE prophylaxis—anticoagulants and … drugs are associated with a higher incidence of bleeding than prophylaxis agents.4 The review’s key … insufficient evidence to draw conclusion regarding whether aspirin is more or less effective than anticoagulation … agents.

55. Final Progress Report: VTE Safety Toolkit: A Systems Approach to Patient Safety (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-02/zierler-report.pdf
    January 01, 2024 - manifest DVT alone, whereas one third of patients manifest PE.1 The recurrent rate of VTE, despite anticoagulant … Improve the use of prophylaxis. … for patients eligible to receive prophylactic anticoagulants. … Five were ineligible for prophylactic anticoagulants due to documented contraindications, such as bleeding … mechanical prophylaxis only.

56. Final Progress Report: VTE Safety Toolkit: A Systems Approach to Patient Safety (pdf file)
    www.ahrq.gov/sites/default/files/2024-02/zierler-report.pdf
    January 01, 2024 - manifest DVT alone, whereas one third of patients manifest PE.1 The recurrent rate of VTE, despite anticoagulant … Improve the use of prophylaxis. … for patients eligible to receive prophylactic anticoagulants. … Five were ineligible for prophylactic anticoagulants due to documented contraindications, such as bleeding … mechanical prophylaxis only.

57. Around the Block | PSNet
    psnet.ahrq.gov/web-mm/around-block
    March 04, 2020 - Risk factors include traumatic needle placement, repeated insertion attempts, and concomitant use with anticoagulants … needle or catheter placement during normal hemostasis, administration of the lowest efficacious dose of anticoagulant … For instance, if an anticoagulant was requested on a patient already receiving a typical neuraxial anesthetic … Anticoagulants and spinal-epidural anesthesia. … administered a dose of LMWH 2 hours preoperatively, because needle placement would occur during peak anticoagulant

58. Appendix A: Tools and Resources | Agency for Healthcare Research and Quality
    www.qualitymeasures.ahrq.gov/patient-safety/settings/hospital/vtguide/appa.html
    July 01, 2018 - Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized … Convincing trials of anticoagulant prophylaxis against symptomatic UE DVT are currently lacking, but … a recent meta-analysis found that anticoagulant prophylaxis is effective for preventing all CVC-related … DVT, and it seems likely that anticoagulant prophylaxis reduces symptomatic UE DVT to some extent. … In any case, most inpatients with a CVC warrant anticoagulant prophylaxis based on cumulative risk factors

59. Appendix A: Tools and Resources | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/vtguide/appa.html
    July 01, 2018 - Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized … Convincing trials of anticoagulant prophylaxis against symptomatic UE DVT are currently lacking, but … a recent meta-analysis found that anticoagulant prophylaxis is effective for preventing all CVC-related … DVT, and it seems likely that anticoagulant prophylaxis reduces symptomatic UE DVT to some extent. … In any case, most inpatients with a CVC warrant anticoagulant prophylaxis based on cumulative risk factors

60. Making Healthcare Safer Practices: 16. Venous Thromboembolism (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
    March 01, 2020 - Pharmacologic prophylaxis is available via a number of different anticoagulant and antiplatelet drugs … There are two different types of pharmacologic agents available for VTE prophylaxis—anticoagulants and … drugs are associated with a higher incidence of bleeding than prophylaxis agents.4 The review’s key … insufficient evidence to draw conclusion regarding whether aspirin is more or less effective than anticoagulation … agents.